HomeCompareKVGOF vs MRK

KVGOF vs MRK: Dividend Comparison 2026

KVGOF yields 19083.97% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KVGOF wins by $32955337985925533696.00M in total portfolio value
10 years
KVGOF
KVGOF
● Live price
19083.97%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32955337985925533696.00M
Annual income
$32,619,104,396,770,110,000,000,000.00
Full KVGOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KVGOF vs MRK

📍 KVGOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKVGOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KVGOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KVGOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KVGOF
Annual income on $10K today (after 15% tax)
$1,622,137.40/yr
After 10yr DRIP, annual income (after tax)
$27,726,238,737,254,596,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KVGOF beats the other by $27,726,238,737,254,596,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KVGOF + MRK for your $10,000?

KVGOF: 50%MRK: 50%
100% MRK50/50100% KVGOF
Portfolio after 10yr
$16477668992962766848.00M
Annual income
$16,309,552,198,385,056,000,000,000.00/yr
Blended yield
98.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KVGOF
No analyst data
Altman Z
20.0
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KVGOF buys
0
MRK buys
0
No recent congressional trades found for KVGOF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKVGOFMRK
Forward yield19083.97%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$32955337985925533696.00M$56.8K
Annual income after 10y$32,619,104,396,770,110,000,000,000.00$9,798.13
Total dividends collected$32933143595212144640.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KVGOF vs MRK ($10,000, DRIP)

YearKVGOF PortfolioKVGOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,919,097$1,908,396.95$11,206$366.19+$1.91MKVGOF
2$344,333,691$342,280,257.29$12,650$502.35+$344.32MKVGOF
3$57,764,311,322$57,395,874,272.37$14,407$694.19+$57764.30MKVGOF
4$9,060,449,929,912$8,998,642,116,797.90$16,585$967.82+$9060449.91MKVGOF
5$1,328,811,832,288,813$1,319,117,150,863,806.50$19,342$1,363.89+$1328811832.27MKVGOF
6$182,228,025,522,437,060$180,806,196,861,888,060.00$22,913$1,947.19+$182228025522.41MKVGOF
7$23,367,928,217,903,067,000$23,172,944,230,594,060,000.00$27,662$2,823.89+$23367928217903.04MKVGOF
8$2,802,173,772,139,107,700,000$2,777,170,088,945,951,000,000.00$34,159$4,173.35+$2802173772139107.50MKVGOF
9$314,236,999,210,676,900,000,000$311,238,673,274,488,050,000,000.00$43,337$6,308.80+$314236999210676864.00MKVGOF
10$32,955,337,985,925,536,000,000,000$32,619,104,396,770,110,000,000,000.00$56,776$9,798.13+$32955337985925533696.00MKVGOF

KVGOF vs MRK: Complete Analysis 2026

KVGOFStock

Kavango Resources Plc, together with its subsidiaries, engages in the exploration of base and precious metals in Botswana. The company explores for nickel, copper, platinum group metals, silver, and rare earth deposits. Its projects include the Kalahari Suture Zone project that consists of 12 prospecting licenses, which covers an area of 7,554 square kilometers located in the southwest of Botswana; the kalahari copper belt project, which comprise of 4 prospecting licenses covering an area of 2,385 square kilometers situated in Botswana; and the Ditau project consists of 2 prospecting licenses that covers an area of 1,386 square kilometers. The company is based in London, the United Kingdom.

Full KVGOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KVGOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KVGOF vs SCHDKVGOF vs JEPIKVGOF vs OKVGOF vs KOKVGOF vs MAINKVGOF vs JNJKVGOF vs ABBVKVGOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.